Beranda › Karsinoma Sel Skuamosa Kepala dan Leher › Ohio › Columbus
Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di Columbus, OH
20 studi untuk Karsinoma Sel Skuamosa Kepala dan Leher mencari peserta di lokasi sekitar Columbus (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Menerima pesertaFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Menerima pesertaFase 1
- ALX Center 10, Columbus
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Menerima pesertaFase 3
- Ohio State University, Columbus
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Menerima pesertaFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 2
- Research Site, Columbus
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Ohio State University, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- Ohio State University, Columbus
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Menerima pesertaFase 2
- Ohio State University, Columbus
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Menerima pesertaFase 2/3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Menerima pesertaFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- The Ohio State University, Columbus
SMP-3124LP in Adults With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Ohio State University, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Ohio State University, Columbus
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
Menerima pesertaFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Menerima pesertaFase 3
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Menerima pesertaFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Menerima peserta
- Ohio State University Medical Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Menerima pesertaFase 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- The Ohio State University, Columbus
Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di kota lain
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- New York City, NY39 studi
- Nashville, TN39 studi
- St. Louis, MO28 studi
- Arlington, VA26 studi
- Philadelphia, PA26 studi
- Chicago, IL26 studi
- Atlanta, GA24 studi
- San Antonio, TX22 studi
- New Haven, CT22 studi
Studi lain di Columbus
- Kanker Paru Non-Sel Kecil57 studi
- Kanker Payudara40 studi
- Kanker Ovarium39 studi
- Kanker (semua jenis)38 studi
- Kanker Paru37 studi
- Leukemia Mieloid Akut35 studi
- Leukemia Limfositik Kronis28 studi
- Kanker Metastatik27 studi
- Kanker Endometrium25 studi
- Kanker Prostat24 studi
- Mieloma Multipel24 studi
- Kanker Kolorektal24 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.